We are proud to announce the opening of our brand new clinic, based in Chelsea
The £12 million facility provides access to exceptional personalised care and state of the art diagnostic services. Patients in South West London can now access Leaders in Oncology Care’s world renowned cancer pathway and survivorship programme, Living Well. A host of supportive services all of which have been proven to help patients cope with their treatment, is also available at this new facility.
Guy Reynolds, VP of Cancer Services for HCA Healthcare UK and Chief Executive Officer of LOC said
“The collaboration with The Lister Hospital allows us to provide the very best in cancer care, whether that’s cutting edge surgery, providing access to clinical trials through Sarah Cannon Research Institute UK, or delivering the most advanced treatment plans and innovative drugs. Throughout the HCA Healthcare UK group we provide an integrated approach to cancer services meaning that our patients have access to excellent care and support during their whole journey and beyond with our survivorship programme Living Well.”
The introduction of LOC at Chelsea reinforces the commitment LOC, Part of HCA Healthcare UK, have to providing the highest standard of patient care in an environment that enables people to feel positive and energised as well as supported and cared for, throughout their cancer journey.
Professor Paul Ellis, Consultant Medical Oncologist, Founding Partner and Medical Director said,
“We started LOC in 2005 to provide the highest standard of cancer treatment and make available the latest treatments, in an environment which enables people to feel positive and energised as well as supported and cared for, physically and emotionally. I am extremely proud to be part of the team launching LOC in Chelsea.
Many of our patients we currently see in central London live in west London and the opening of this brand new facility will enable us to expand our cancer services and in collaboration with The Lister Hospital, allow us to continue to provide of cancer care to our patients closer to where they live”